GenomeKey
About:
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology.
Website: https://genomekey.com/
Top Investors: CARB-X
Description:
GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges.
Total Funding Amount:
$3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Bristol, Bristol, City of, United Kingdom
Founded Date:
2019-01-01
Contact Email:
info(AT)genomekey.com
Founders:
Chris Heys, David Davies, Michael Roberts
Number of Employees:
11-50
Last Funding Date:
2021-04-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai